A GMP Protocol for the Manufacture of Tregs for Clinical Application.

Methods in molecular biology (Clifton, N.J.)(2023)

引用 1|浏览4
暂无评分
摘要
Infusion of regulatory T cells is a promising therapeutic strategy in organ transplantation to modulate the immune system, prevent rejection, minimize the need for pharmaceutical immunosuppression, and improve long-term transplant outcomes. Here we describe a GMP-compliant method we have used for the manufacture of ex vivo expanded autologous regulatory T cells for use in clinical trials.
更多
查看译文
关键词
Immunosuppression minimization,Regulatory T cells,Tolerance,Transplantation,Treg
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要